Retrospective Cohort Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Oct 7, 2019; 25(37): 5630-5640
Published online Oct 7, 2019. doi: 10.3748/wjg.v25.i37.5630
Figure 1
Figure 1 Influence of post-transplant infection on overall survival of hepatocellular carcinoma patients treated by orthotopic liver transplantation. The Kaplan-Meier curve shows overall survival of the patients according to the post-transplant infection status. PTI: Post-transplant infection; PRS: Post-recurrence survival; OLT: Orthotopic liver transplantation.
Figure 2
Figure 2 Influence of post-transplant infection on overall survival and recurrence-free survival of transplant hepatocellular carcinoma patients subgrouped by vascular invasion status. A: Kaplan-Meier overall survival (OS) curve for patients with vascular invasion (VI) classified according to the post-transplant infection (PTI) status (P = 0.003); B: Kaplan-Meier OS curves for patients without VI classified according to the PTI status (P = 0.404); C: Kaplan-Meier recurrence-free survival (RFS) curve for patients with VI classified according to the PTI status (P = 0.003); D: Kaplan-Meier RFS curve for patients without VI classified according to the PTI status (P = 0.251). PTI: Post-transplant infection; OLT: Orthotopic liver transplantation.
Figure 3
Figure 3 Influence of post-transplant infection on overall survival and post-recurrence survival of transplant hepatocellular carcinoma patients with tumor relapse. A: Kaplan-Meier overall survival curve of patients with recurrent tumors stratified by post-transplant infection (PTI) status (P = 0.026); B: Kaplan-Meier post-recurrence survival curve of patients with recurrent tumors stratified by PTI status (P = 0.042). PTI: Post-transplant infection; OS: Overall survival; OLT: Orthotopic liver transplantation.